Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ischemic Heart Disease

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 89 articles:
HTML format



Single Articles


    May 2022
  1. UEMURA T
    Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO.
    JAMA. 2022;327:1928.
    PubMed    


  2. PAPPALARDO F, Montisci A
    Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO.
    JAMA. 2022;327:1927-1928.
    PubMed    


  3. LEVY B, Combes A, Girerd N
    Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO-Reply.
    JAMA. 2022;327:1928-1929.
    PubMed    


    April 2022
  4. DAVIDSON KW, Barry MJ, Mangione CM, Cabana M, et al
    Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;327:1577-1584.
    PubMed     Abstract available


  5. BRETT AS
    Should Patients Take Aspirin for Primary Cardiovascular Prevention?: Updated Recommendations From the US Preventive Services Task Force.
    JAMA. 2022;327:1552-1554.
    PubMed    


  6. JIN J
    Use of Aspirin to Prevent Cardiovascular Disease.
    JAMA. 2022;327:1624.
    PubMed    


  7. GUIRGUIS-BLAKE JM, Evans CV, Perdue LA, Bean SI, et al
    Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022;327:1585-1597.
    PubMed     Abstract available


  8. DEHMER SP, O'Keefe LR, Evans CV, Guirguis-Blake JM, et al
    Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force.
    JAMA. 2022;327:1598-1607.
    PubMed     Abstract available


  9. ABBASI J
    Highlights From the American College of Cardiology's Scientific Sessions-New Heart Failure Management Guidelines, Alirocumab After a Myocardial Infarction, and Treating Mild Chronic Hypertension in Pregnancy.
    JAMA. 2022 Apr 20. pii: 2791572. doi: 10.1001/jama.2022.5487.
    PubMed    


  10. RABER L, Ueki Y, Otsuka T, Losdat S, et al
    Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
    JAMA. 2022 Apr 3. pii: 2790913. doi: 10.1001/jama.2022.5218.
    PubMed     Abstract available


    March 2022
  11. BRUXVOORT K, Slezak J, Qian L, Sy LS, et al
    Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
    JAMA. 2022 Mar 25. pii: 2790492. doi: 10.1001/jama.2022.2540.
    PubMed     Abstract available


  12. LIN YH
    Mental Stress-Induced Myocardial Ischemia and Cardiovascular Events in Patients With Coronary Heart Disease.
    JAMA. 2022;327:1091.
    PubMed    


  13. VACCARINO V, Bremner JD, Quyyumi AA
    Mental Stress-Induced Myocardial Ischemia and Cardiovascular Events in Patients With Coronary Heart Disease-Reply.
    JAMA. 2022;327:1091-1092.
    PubMed    


  14. ABBASI J
    The COVID Heart-One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks.
    JAMA. 2022 Mar 2. pii: 2789793. doi: 10.1001/jama.2022.2411.
    PubMed    


  15. DALZELL JR
    Review of Cardiogenic Shock After Acute Myocardial Infarction.
    JAMA. 2022;327:878.
    PubMed    


  16. SAMSKY MD, Rao SV
    Review of Cardiogenic Shock After Acute Myocardial Infarction-Reply.
    JAMA. 2022;327:879.
    PubMed    


    February 2022
  17. BHATT DL, Lopes RD, Harrington RA
    Diagnosis and Treatment of Acute Coronary Syndromes: A Review.
    JAMA. 2022;327:662-675.
    PubMed     Abstract available


  18. LEVY B, Girerd N, Amour J, Besnier E, et al
    Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical Trial.
    JAMA. 2022;327:442-453.
    PubMed     Abstract available


    January 2022
  19. ABBASI J
    Highlights From the American Heart Association's Scientific Sessions-ApoB as a Risk Marker, an Oral PCSK9 Inhibitor, and Aspirin and Dementia.
    JAMA. 2022;327:310-312.
    PubMed    


    December 2021
  20. SLOMSKI A
    Tirzepatide Tested for Type 2 Diabetes With High Cardiovascular Risk.
    JAMA. 2021;326:2464.
    PubMed    


  21. GREENE SJ, Butler J, Fonarow GC
    Contextualizing Risk Among Patients With Heart Failure.
    JAMA. 2021;326:2261-2262.
    PubMed    


  22. RAY KK, Wright RS
    Clinical Update on Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk.
    JAMA. 2021;326:2205.
    PubMed    


  23. WILKINS JT, Lloyd-Jones DM
    Clinical Update on Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk-Reply.
    JAMA. 2021;326:2205-2206.
    PubMed    


    November 2021
  24. NACHTIGALL M, Nachtigall RH
    The Role of Lipoprotein(a) in Cardiovascular Diseases.
    JAMA. 2021;326:2078.
    PubMed    


  25. NATARAJAN P, Miksenas H, Januzzi JL Jr
    The Role of Lipoprotein(a) in Cardiovascular Diseases-Reply.
    JAMA. 2021;326:2078-2079.
    PubMed    


  26. SLOMSKI A
    Intensive Blood Pressure Control Lowers Cardiovascular Risk.
    JAMA. 2021;326:2001.
    PubMed    


  27. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
    Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
    JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.
    PubMed    


  28. AMINIAN A, Al-Kurd A, Wilson R, Bena J, et al
    Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
    JAMA. 2021 Nov 11. pii: 2786270. doi: 10.1001/jama.2021.19569.
    PubMed     Abstract available


  29. VACCARINO V, Almuwaqqat Z, Kim JH, Hammadah M, et al
    Association of Mental Stress-Induced Myocardial Ischemia With Cardiovascular Events in Patients With Coronary Heart Disease.
    JAMA. 2021;326:1818-1828.
    PubMed     Abstract available


  30. SAMSKY MD, Morrow DA, Proudfoot AG, Hochman JS, et al
    Cardiogenic Shock After Acute Myocardial Infarction: A Review.
    JAMA. 2021;326:1840-1850.
    PubMed     Abstract available


  31. BRAVO PE, Cappola TP
    Mental Stress-Induced Myocardial Ischemia: When the Mind Controls the Fate of the Heart.
    JAMA. 2021;326:1803-1804.
    PubMed    


    October 2021
  32. SAAD M, Kennedy KF, Imran H, Louis DW, et al
    Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction.
    JAMA. 2021 Oct 29. pii: 2785893. doi: 10.1001/jama.2021.18890.
    PubMed     Abstract available


  33. FANAROFF AC, Garcia S, Giri J
    Myocardial Infarction During the COVID-19 Pandemic.
    JAMA. 2021 Oct 29. pii: 2785894. doi: 10.1001/jama.2021.19608.
    PubMed    


  34. HE J, Zhu Z, Bundy JD, Dorans KS, et al
    Trends in Cardiovascular Risk Factors in US Adults by Race and Ethnicity and Socioeconomic Status, 1999-2018.
    JAMA. 2021;326:1286-1298.
    PubMed     Abstract available


    September 2021
  35. ZUIN M, Rigatelli G, Zuliani G
    Association of Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention With Memory Decline in Older Adults.
    JAMA. 2021;326:1212-1213.
    PubMed    


  36. WHITLOCK EL, Glymour MM
    Association of Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention With Memory Decline in Older Adults-Reply.
    JAMA. 2021;326:1213.
    PubMed    


    August 2021

  37. Worse Cardiovascular Outcomes Found in Disadvantaged Areas.
    JAMA. 2021;326:591.
    PubMed    


    July 2021
  38. SLOMSKI A
    Fewer Cardiovascular Events With Intensive Blood Pressure Control.
    JAMA. 2021;326:299.
    PubMed    


  39. WILKINS JT, Lloyd-Jones DM
    Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk.
    JAMA. 2021;326:266-267.
    PubMed    


  40. MIKSENAS H, Januzzi JL Jr, Natarajan P
    Lipoprotein(a) and Cardiovascular Diseases.
    JAMA. 2021 Jul 8. pii: 2781946. doi: 10.1001/jama.2021.3632.
    PubMed    


    June 2021
  41. SATO T, Terada R, Ikeda T
    Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia.
    JAMA. 2021;325:2505-2506.
    PubMed    


  42. DUCROCQ G, Simon T, Steg PG
    Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia-Reply.
    JAMA. 2021;325:2506-2507.
    PubMed    


  43. SOLOMON MD, Nguyen-Huynh M, Leong TK, Alexander J, et al
    Changes in Patterns of Hospital Visits for Acute Myocardial Infarction or Ischemic Stroke During COVID-19 Surges.
    JAMA. 2021 Jun 2. pii: 2780794. doi: 10.1001/jama.2021.8414.
    PubMed    


    May 2021
  44. GOTTESMAN RF, Johansen MC
    Coronary Revascularization and Cognitive Decline: The Patient or the Procedure?
    JAMA. 2021;325:1941-1942.
    PubMed    


  45. OGATA H, Fukagawa M, Hirakata H, Kagimura T, et al
    Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
    JAMA. 2021;325:1946-1954.
    PubMed     Abstract available


  46. WHITLOCK EL, Diaz-Ramirez LG, Smith AK, Boscardin WJ, et al
    Association of Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention With Memory Decline in Older Adults Undergoing Coronary Revascularization.
    JAMA. 2021;325:1955-1964.
    PubMed     Abstract available


  47. JOSHI PH, de Lemos JA
    Diagnosis and Management of Stable Angina: A Review.
    JAMA. 2021;325:1765-1778.
    PubMed     Abstract available


    April 2021
  48. EL-BATTRAWY I, Behnes M, Akin I
    Depression and Incident Cardiovascular Disease.
    JAMA. 2021;325:1679-1680.
    PubMed    


  49. DAVIDSON KW, Pennells L, Di Angelantonio E
    Depression and Incident Cardiovascular Disease-Reply.
    JAMA. 2021;325:1680.
    PubMed    


  50. ANCHAN R, Cifu AS, Paul J
    Management of Acute Coronary Syndromes in Patients Without Persistent ST-Segment Elevation.
    JAMA. 2021;325:1556-1557.
    PubMed    


  51. RIGATELLI G, Zuin M
    Fractional Flow Reserve Treatment and Major Adverse Cardiac Events in Patients With Coronary Artery Disease.
    JAMA. 2021;325:1565.
    PubMed    


  52. SUD M, Fang J, Ko DT
    Fractional Flow Reserve Treatment and Major Adverse Cardiac Events in Patients With Coronary Artery Disease-Reply.
    JAMA. 2021;325:1565-1566.
    PubMed    


  53. KAMRAN H, Jneid H, Kayani WT, Virani SS, et al
    Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review.
    JAMA. 2021;325:1545-1555.
    PubMed     Abstract available


  54. WANG Y
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1333.
    PubMed    


  55. OLSHANSKY B, Bhatt DL, Chung MK
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1332-1333.
    PubMed    


  56. PARK KY, Park HK, Hwang HS
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1334.
    PubMed    


  57. WELTY F, Bistrian B, Driscoll D
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1333.
    PubMed    


  58. NISSEN SE, Lincoff AM, Nicholls SJ
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk-Reply.
    JAMA. 2021;325:1334-1335.
    PubMed    


    March 2021
  59. SLOMSKI A
    Polypill Plus Aspirin Effective for Cardiovascular Disease Prevention.
    JAMA. 2021;325:1135.
    PubMed    


  60. FRIEDEN TR, Foti KE
    National Initiatives to Prevent Myocardial Infarction and Stroke.
    JAMA. 2021 Mar 12. pii: 2777651. doi: 10.1001/jama.2021.0905.
    PubMed    


  61. YOU SC, Gupta A, Krumholz HM
    Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Intervention-Reply.
    JAMA. 2021;325:890-891.
    PubMed    


  62. KIM HK, Kubica J, Jeong YH
    Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Intervention.
    JAMA. 2021;325:890.
    PubMed    


    February 2021
  63. KOLTE D, Libby P, Jang IK
    New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes.
    JAMA. 2021 Feb 22. pii: 2776938. doi: 10.1001/jama.2021.0069.
    PubMed    


  64. PERAK AM, Lancki N, Kuang A, Labarthe DR, et al
    Associations of Maternal Cardiovascular Health in Pregnancy With Offspring Cardiovascular Health in Early Adolescence.
    JAMA. 2021;325:658-668.
    PubMed     Abstract available


  65. DANIELS SR
    Maternal Cardiovascular Health: A Critical Period for Offspring Lifetime Cardiovascular Health?
    JAMA. 2021;325:630-631.
    PubMed    


  66. DUCROCQ G, Gonzalez-Juanatey JR, Puymirat E, Lemesle G, et al
    Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial.
    JAMA. 2021;325:552-560.
    PubMed     Abstract available


  67. KHATANA SAM, Venkataramani AS, Nathan AS, Dayoub EJ, et al
    Association Between County-Level Change in Economic Prosperity and Change in Cardiovascular Mortality Among Middle-aged US Adults.
    JAMA. 2021;325:445-453.
    PubMed     Abstract available


  68. WEEKS WB, Weinstein JN
    Economic Prosperity and Cardiovascular Mortality: Further Evidence That All Policy Is Health Policy.
    JAMA. 2021;325:439-440.
    PubMed    


    January 2021
  69. LOPES RD, Macedo AVS, de Barros E Silva PGM, Moll-Bernardes RJ, et al
    Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial.
    JAMA. 2021;325:254-264.
    PubMed     Abstract available


    December 2020
  70. SLOMSKI A
    Empagliflozin Cuts Cardiovascular Deaths in Advanced Heart Failure.
    JAMA. 2020;324:2476.
    PubMed    


  71. HARSHFIELD EL, Pennells L, Schwartz JE, Willeit P, et al
    Association Between Depressive Symptoms and Incident Cardiovascular Diseases.
    JAMA. 2020;324:2396-2405.
    PubMed     Abstract available


  72. PATEL MM, Uyeki TM
    Influenza Vaccine for Patients With High-risk Cardiovascular Disease.
    JAMA. 2020 Dec 4. pii: 2773988. doi: 10.1001/jama.2020.23948.
    PubMed    


  73. VARDENY O, Kim K, Udell JA, Joseph J, et al
    Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
    JAMA. 2020 Dec 4. pii: 2773989. doi: 10.1001/jama.2020.23649.
    PubMed     Abstract available


    November 2020
  74. KRIST AH, Davidson KW, Mangione CM, Barry MJ, et al
    Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2020;324:2069-2075.
    PubMed     Abstract available


  75. O'CONNOR EA, Evans CV, Rushkin MC, Redmond N, et al
    Behavioral Counseling to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2020;324:2076-2094.
    PubMed     Abstract available


  76. JIN J
    Counseling on Healthy Diet and Physical Activity to Prevent Cardiovascular Disease.
    JAMA. 2020;324:2114.
    PubMed    


  77. SMILOWITZ NR, Berger JS
    Cardiovascular Risk Assessment for Noncardiac Surgery-Reply.
    JAMA. 2020;324:2106-2107.
    PubMed    


  78. GRASSHOFF C, Magunia H
    Cardiovascular Risk Assessment for Noncardiac Surgery.
    JAMA. 2020;324:2105-2106.
    PubMed    


  79. KHAN SS, Greenland P
    Comprehensive Cardiovascular Health Promotion for Successful Prevention of Cardiovascular Disease.
    JAMA. 2020;324:2036-2037.
    PubMed    


  80. SHARMA G, Martin SS, Blumenthal RS
    Effects of Omega-3 Fatty Acids on Major Adverse Cardiovascular Events: What Matters Most: the Drug, the Dose, or the Placebo?
    JAMA. 2020 Nov 15. pii: 2773118. doi: 10.1001/jama.2020.22387.
    PubMed    


  81. NICHOLLS SJ, Lincoff AM, Garcia M, Bash D, et al
    Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
    JAMA. 2020 Nov 15. pii: 2773120. doi: 10.1001/jama.2020.22258.
    PubMed     Abstract available


  82. SUD M, Han L, Koh M, Austin PC, et al
    Association Between Adherence to Fractional Flow Reserve Treatment Thresholds and Major Adverse Cardiac Events in Patients With Coronary Artery Disease.
    JAMA. 2020 Nov 13. pii: 2773127. doi: 10.1001/jama.2020.22708.
    PubMed     Abstract available


  83. BACH RG
    Physiology-Based Revascularization Decisions and Improved Clinical Outcomes Following Percutaneous Coronary Interventions.
    JAMA. 2020 Nov 13. pii: 2773126. doi: 10.1001/jama.2020.22998.
    PubMed    


    October 2020
  84. SLOMSKI A
    Colchicine Reduces Cardiovascular Events in Chronic Coronary Disease.
    JAMA. 2020;324:1599.
    PubMed    


  85. BATES ER
    Net Adverse Clinical Events With Antiplatelet Therapy in Acute Coronary Syndromes.
    JAMA. 2020;324:1613-1615.
    PubMed    


  86. YOU SC, Rho Y, Bikdeli B, Kim J, et al
    Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    JAMA. 2020;324:1640-1650.
    PubMed     Abstract available


    June 2020
  87. HADAYA J, Benharash P
    Extracorporeal Membrane Oxygenation.
    JAMA. 2020;323:2536.
    PubMed    


    May 2020
  88. HIRSCH IB, Gaudiani LM
    Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020.
    JAMA. 2020 May 22. pii: 2766597. doi: 10.1001/jama.2020.1303.
    PubMed    


    February 2020
  89. THIELE H, Desch S, Freund A
    Microaxial Left Ventricular Assist Devices: In Search of an Appropriate Indication.
    JAMA. 2020;323:716-718.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: